Mark R. Alderson

机构：Program for Appropriate Technology in Health · ORCID：0000-0002-0697-6149

发表论文 136 篇 · 总被引 15122 次 · h-index 63

代表论文

• TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization (2011 · Cell Host & Microbe · 被引 192)
• Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys (2009 · Proceedings of the National Academy of Sciences · 被引 167)
• WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016 (2016 · Vaccine · 被引 104)
• Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine (2010 · Clinical and Vaccine Immunology · 被引 102)
• GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis (2010 · Vaccine · 被引 99)
• Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid–CbpA Peptide Recombinant Fusion Protein (2013 · The Journal of Infectious Diseases · 被引 87)